In Brief: Novartis
This article was originally published in The Tan Sheet
Executive Summary
Novartis: Ciba Geigy/Sandoz merger is one step closer to completion following the approval by the European Commission, the firms announce July 17. The companies are still waiting for approval by U.S. regulatory authorities including FTC and the Justice Department; "substantial progress has been achieved with the FTC," Ciba and Sandoz noted. The firms announced their intention to merge on March 7 ("The Tan Sheet" March 11, p. 1). Fred Huser, current Sandoz U.S. consumer pharmaceuticals president, will head Novartis' U.S. self-medication business ("The Tan Sheet" May 13, p. 6)...